Xen Capital

Xen Capital is an alternative investment platform that provides accredited investors with access to high-quality investment opportunities traditionally reserved for ultra-high-net-worth individuals and institutional investors. Founded in 2018 by a team of experienced professionals from finance and technology sectors, the company addresses the barriers that often prevent Asian investors from participating in alternative investments, such as private equity, venture capital, real estate, and hedge funds. Through its user-friendly fintech solution, Xen Capital enables fractionalized access and liquidity in these investments, enhancing transparency and efficiency. The platform incorporates an AI-powered onboarding process and allows for seamless subscription to top-tier funds, empowering investors with greater autonomy in their decision-making. By leveraging technology, Xen Capital aims to democratize access to alternative asset management, making it more accessible and transparent for accredited investors.

Manish Sansi

Co-Founder

1 past transactions

Prenetics

Post in 2022
Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.